All the need-to-know items about the latest #oncopharm approved drug, tazemetostat, to start the Pod.  We end (9:15) with a brief discussion of how gut bacteria may lead to gemcitabine resistance.

All the need-to-know items about the latest #oncopharm approved drug, tazemetostat, to start the Pod.  We end

NK - 1 Antagonist Drug Interactions

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.